Long-Term Effects of Serratus Anterior Plane Block SAPB Versus Standard Pain Relief in Adults with Multiple Unilateral Rib Fractures

What this Trial Is About

Researchers are studying the long-term effects of the serratus anterior plane block SAPB in adults with multiple unilateral anterolateral rib fractures who arrive at the emergency department within 24 hours of injury. The study aims to compare SAPB to standard opioid-based pain treatments to see if SAPB reduces complications like pneumonia, hospital stay length, discharge outcomes, and death. This observational study is conducted at a single urban trauma center. Patients eligible for the study will receive SAPB if a trained physician is available within 24 hours otherwise, they will receive intravenous opioid analgesia. The SAPB involves ultrasound-guided injection of local anesthetic between muscles to target nerves for pain relief. Ultrasound imaging is used during the procedure to ensure correct needle placement and anesthetic spread. The study follows patients until discharge or up to 60 days. Participants will be monitored for outcomes such as hospital-acquired pneumonia, length of hospital and ICU stays, discharge disposition, and mortality within 90 days. Pain intensity is assessed before and after SAPB, and the need for additional analgesia is tracked within 24 hours. Data collection includes ultrasound images, clinical assessments, and patient consent. The study seeks to understand if SAPB improves recovery compared to standard pain management.

Assessment of Morbidity and Mortality Following Serratus Anterior Plane Block (SAPB) for Unilateral Rib Fractures